Combination of Plasma MIF and VCA-IgA Improves the Diagnostic Specificity for Patients With Nasopharyngeal Carcinoma.

CONCLUSION: The combination of macrophage migration inhibitory factor and Epstein-Barr virus viral capsid antigen increases the specificity and positive predictive value of detecting nasopharyngeal carcinoma and improves the diagnostic accuracy of nasopharyngeal carcinoma in high-risk individuals.
PMID: 32578505 [PubMed - in process]

Source: Technology in Cancer Research and Treatment - December 31, 2019 Category: Cancer & Oncology Authors: Xue N, Xing S, Ma W, Sheng J, Huang Z, Xu Q Tags: Technol Cancer Res Treat Source Type: research